ClinicalTrials.gg
Drug

Tezacaftor clinical trials

Also written VX-661.

studies test it
43
open now
4
in phase 3
25
first study started
2012

Counted the way a researcher would: Tezacaftor with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses tezacaftor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tezacaftor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Dec 2024 · ALYFTREK · NDA 218730 (FDA, Drugs@FDA; in a combination)
European Union
31 Oct 2018 · Symkevi · EMEA/H/C/004682 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tezacaftor
6
TEZ
6

Development codes

VX-661
9

In one entry with another drug

Given together, or one or the other

elexacaftor/tezacaftor/ivacaftor
17
Tezacaftor/Ivacaftor
11
VX-661/VX-770
9
TEZ/IVA; VX-661/VX-770
2
VX-661 Plus Ivacaftor Combination
2

Studies by the year they started

43 studies that test it; most in 2016 (6)

Studies that test tezacaftor, by start year
YearStudies
20121
20142
20155
20166
20173
20185
20192
20205
20213
20224
20232
20241
20252
20262

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
10
Phase 3
25
Phase 4
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 39 · Other 4

Vertex Pharmaceuticals Incorporated (39) · Royal College of Surgeons, Ireland (1) · Nottingham University Hospitals NHS Trust (1) · Istituto Giannina Gaslini (1) · Arkansas Children's Hospital Research Institute (1)

Often tested with

Tested in the same studies.

Ivacaftor (39) · Elexacaftor (20) · Olacaftor (2) · VX-828 (1) · Vanzacaftor (1) · VX-659 (1) · VX-152 (1) · Ciprofloxacin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 2 in phase 3

Studies that test tezacaftor, phase 3 first.

Studies

Open first, then newest update. How each study uses tezacaftor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 43

See all 43 studies that test tezacaftor →

Given beside what is tested · 5 — tezacaftor is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with tezacaftor

Codes

What other systems call tezacaftor · ClinicalTrials.gg INT000846

  • MeSH (NLM) C000625213tezacaftorOne source NLM
  • UNII (FDA) 8RW88Y506KTEZACAFTORConfirmed FDA, NLM, Wikidata
  • RxNorm 1999382Confirmed FDA, Wikidata
  • Wikidata Q27270940tezacaftorConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152581TezacaftorOne source FDA
  • DrugBank DB11712One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.